Travere Therapeutics, Inc. reports

Company location: San Diego, CA
Fiscal year end: 31 December

Travere Therapeutics, Inc. has filed 1,280 SEC EDGAR filings since 27 Jun 2008

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 626-650 of 1,000 matching filings.

Per page

25

Current page

26

4

FORM 4 SUBMISSION

Filing date: 03 Feb 2021
Reporting date: 03 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Feb 2021
Reporting date: 03 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 02 Feb 2021
Reporting date: 31 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 02 Feb 2021
Reporting date: 31 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 02 Feb 2021
Reporting date: 31 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 02 Feb 2021
Reporting date: 31 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 02 Feb 2021
Reporting date: 31 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 02 Feb 2021
Reporting date: 02 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36257

8-K

Filing date: 02 Feb 2021
Reporting date: 02 Feb 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13G/A File 005-87088

SC 13G/A filing

Filing date: 01 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4/A

FORM 4/A SUBMISSION

Filing date: 28 Jan 2021
Reporting date: 21 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 25 Jan 2021
Reporting date: 21 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 25 Jan 2021
Reporting date: 21 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 25 Jan 2021
Reporting date: 21 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 25 Jan 2021
Reporting date: 21 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 25 Jan 2021
Reporting date: 21 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 25 Jan 2021
Reporting date: 21 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36257

8-K

Filing date: 11 Jan 2021
Reporting date: 11 Jan 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 07 Jan 2021
Reporting date: 05 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 07 Jan 2021
Reporting date: 05 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-87088

TRAVERE THERAPEUTICS, INC.

Filing date: 04 Jan 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 16 Dec 2020
Reporting date: 15 Dec 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 04 Dec 2020
Reporting date: 02 Dec 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 25 Nov 2020
Reporting date: 23 Nov 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36257

8-K

Filing date: 18 Nov 2020
Reporting date: 12 Nov 2020
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .